Noxopharm Ltd (NOX) — Cash Flow-to-Debt Ratio
Noxopharm Ltd (NOX) has a Cash Flow-to-Debt Ratio of -0.46x as of December 2025, meaning its operating cash flow of AU$-2.71 Million could theoretically repay 0% of its total liabilities (AU$5.88 Million) in one year. Explore long-term investment intensity of Noxopharm Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Noxopharm Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Noxopharm Ltd across 10 annual periods. Also explore NOX asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Noxopharm Ltd (2016–2025)
Year-by-year debt coverage analysis for Noxopharm Ltd. For market capitalisation and broader financial context, see market value of Noxopharm Ltd.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.50x | AU$-5.82 Million | AU$3.89 Million | ▼ -181.9% |
| 2024 | -0.53x | AU$-684.31K | AU$1.29 Million | ▲ +94.9% |
| 2023 | -10.37x | AU$-10.95 Million | AU$1.06 Million | ▼ -87.0% |
| 2022 | -5.55x | AU$-13.73 Million | AU$2.48 Million | ▼ -343.6% |
| 2021 | -1.25x | AU$-8.85 Million | AU$7.08 Million | ▲ +19.2% |
| 2020 | -1.55x | AU$-11.14 Million | AU$7.19 Million | ▲ +8.9% |
| 2019 | -1.70x | AU$-9.78 Million | AU$5.75 Million | ▲ +17.6% |
| 2018 | -2.06x | AU$-9.08 Million | AU$4.40 Million | ▲ +74.5% |
| 2017 | -8.08x | AU$-2.92 Million | AU$361.04K | ▼ -284.8% |
| 2016 | -2.10x | AU$-549.72K | AU$261.72K | — |